Sorafenib and Vinorelbine in Treating Women With Stage IV Breast Cancer
NCT00828074
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
46
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
sorafenib tosylate
DRUG:
vinorelbine ditartrate
Sponsor
City of Hope Medical Center
Collaborators
[object Object]